Une approche participative pour la prévention du diabète de type 2 chez les jeunes francophones du Nouveau-Brunswick

2004 ◽  
Vol 65 (1) ◽  
pp. 15-21 ◽  
Author(s):  
Lita Villalon ◽  
Cédée-Anne Leclair
Keyword(s):  
Public Health ◽  
Type 2 Diabetes ◽  
New Brunswick ◽  
School Environment ◽  
Eating Habits ◽  
Intervention Strategy ◽  
Public Health Problem ◽  
Healthy Eating Habits ◽  
Prevention Of Diabetes

A participatory approach for the prevention of type 2 diabetes for francophone youth of New Brunswick Diabetes, a serious public health problem, is on the rise, claiming millions of victims. A considerable body of research exists on diabetes, but the development of effective primary prevention strategies is just beginning. This article presents the results of a project, based on an innovative approach where health professionals and community groups have come together to address the issue. The purpose of the project is to develop an intervention strategy for the prevention of type 2 diabetes directed at young francophones living in a minority environment in New Brunswick and adapted to their needs. Qualitative data were gathered from two focus groups and submitted for a content analysis. The process was evaluated. The young francophones have identified the school environment as ideal for intervention. According to them, the intervention should be adapted to the age of the youths. For the 5-to-13-year-old group, the intervention should target healthy eating habits and physical activity whereas for the 14-to-18-year-old group, the emphasis should be on preventing diabetes. The youth and the professionals acquired a greater understanding of the problem of diabetes and its prevention. Youth can now proceed to action, with appropriate guidance. The experience and knowledge of the professionals contributed to the development of the strategy. A shortage of dietitians in public health to work in the area of the prevention of diabetes has been noted.

scholarly journals Natural Ingredients from Medicine Food Homology as Chemopreventive Reagents against Type 2 Diabetes Mellitus by Modulating Gut Microbiota Homoeostasis

Molecules ◽  
2021 ◽  
Vol 26 (22) ◽  
pp. 6934
Author(s):  
Xiaoyan Xia ◽  
Jiao Xiao
Keyword(s):  
Public Health ◽  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Gut Microbiota ◽  
Functional Food ◽  
Public Health Problem ◽  
Healthy Life ◽  
Gut Microbiota Dysbiosis

Type 2 diabetes mellitus (T2DM) is a noteworthy worldwide public health problem. It represents a complex metabolic disorder, mainly characterized as hyperglycemia and lipid dysfunction. The gut microbiota dysbiosis has been proposed to play a role in the development of diabetes. Recently, there has been considerable interest in the use of medicine food homology (MFH) and functional food herbs (FF) to ameliorate diabetes and lead to a natural and healthy life. Hence, this review compiles some reports and findings to demonstrate that the practical use of the MFH/FF can modulate the homoeostasis of gut microbiota, thereby ameliorating the development of T2DM. The results provided useful data to support further investigation of the functional basis and application of MFH/FF to treat T2DM through maintaining intestinal homeostasis.

scholarly journals Type 2 Diabetes in Children: A Growing Epidemic

2006 ◽  
Vol 11 (4) ◽  
pp. 212-222 ◽  
Author(s):  
Erin L. St. Onge ◽  
Carol A. Motycka ◽  
Renee L. Rose
Keyword(s):  
Type 2 Diabetes ◽  
Eating Habits ◽  
Pediatric Population ◽  
Lifestyle Changes ◽  
Obesity And Diabetes ◽  
Population Type ◽  
Children Obesity ◽  
Healthy Eating Habits ◽  
Diabetes And Obesity

In the pediatric population, type 2 diabetes has become a growing concern. A correlation appears to exist among type 2 diabetes in children, obesity, and a sedentary lifestyle. If obesity and diabetes are left untreated, conditions such as cardiovascular disease, nephropathy, and retinopathy may result as well. These conditions indicate the incredible strain on the health care system caused by diabetes and obesity. This strain may be eased by logical treatments such as exercise and healthy eating habits for the child and family. However, these lifestyle changes are not always effective in controlling blood sugar. When lifestyle changes do not yield positive results, the clinician must decide which (if any) pharmacological treatments are safe to use in the pediatric population. Orlistat and sibutramine have been studied in children as treatments for obesity and appear to be safe and effective for this population. Metformin and insulin are among the medications approved to treat diabetes in children and adolescents. Healthcare practitioners must play a role in educating parents and their children about the effects of obesity on the development of diseases like diabetes, as well as various therapies used to manage diabetes. In addition, healthcare practitioners can assist patients and their parents in understanding the benefits and risks of medications used in the treatment of the disease, assistance that may result in them making informed decisions regarding their overall health.

scholarly journals Digital Support for Healthier Eating Habits Among Patients With Type 2 Diabetes: Protocol for a Randomized Clinical Trial Within Primary Care (HAPPY Trial) (Preprint)

2020 ◽  
Author(s):  
Ylva Trolle Lagerros ◽  
Anna Dahlgren ◽  
Linnea Sjöblom ◽  
Stephanie E Bonn
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Dietary Intake ◽  
Randomized Clinical Trial ◽  
Healthy Eating ◽  
Eating Habits ◽  
Lifestyle Factors ◽  
Smartphone App ◽  
Healthy Eating Habits

BACKGROUND Despite the large impact that dietary habits have in the management of diabetes, few tools for supporting healthy eating habits are available for persons with diabetes. OBJECTIVE The aim of this randomized clinical trial is to evaluate the effect of a 12-week, mobile health (mHealth), app-based intervention promoting healthy eating habits among patients with type 2 diabetes. METHODS The HAPPY (Healthy eating using APP technologY) trial is a randomized clinical trial with two arms aiming to include 200 patients, 18 years of age or older, with type 2 diabetes. Both women and men are eligible for inclusion. Study participants are randomized 1:1 to an intervention group, where they are instructed to use a smartphone app promoting healthy eating, or to a control group, where they receive standard primary care only, for a period of 12 weeks. Each week a new topic (eg, vegetable intake) is introduced via the app. After an introduction text, the user is given a topic-related activity to perform (eg, eat one additional serving of vegetables per day during that week). The app records daily progress and sends automatic reminders or feedback to the user. Dietary intake, body composition, clinical variables, and biomarkers are measured at baseline and at 3- and 6-month follow-ups. An extensive web-based questionnaire comprising several validated questionnaires assessing a number of lifestyle factors is distributed via email at baseline and at 3-, 6-, and 12-month follow-ups; lifestyle factors include, for example, sleep, physical activity, eating behavior, and health-related quality of life. The effect of the intervention on dietary intake (primary outcome) and on glycated hemoglobin and blood lipid levels, body composition, blood pressure, other lifestyle factors, and overall health (secondary outcomes) will be assessed. RESULTS Data collection is ongoing. Recruitment of participants started in January 2019. Findings from the study are expected to be published by the end of 2021. CONCLUSIONS Technology development provides new ways to promote and support long-term adherence to healthier eating habits. mHealth-based approaches allow for real-time interaction and the delivery of an intervention at any time. Further, focusing on overall diet allows the user to apply new knowledge to current eating patterns, creating an individualized approach. In this study, we evaluate the effect of using a new smartphone app promoting healthy eating habits on dietary intake, clinical markers, and lifestyle factors among patients with type 2 diabetes. CLINICALTRIAL ClinicalTrials.gov NCT03784612; https://clinicaltrials.gov/ct2/show/NCT03784612 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/24422

scholarly journals Ghrelin, Diabetes and Obesity - Prospects for an Anti-obesity Vaccine

JMS SKIMS ◽  
2011 ◽  
Vol 14 (2) ◽  
pp. 38-39
Author(s):  
Shariq R Masoodi
Keyword(s):  
Public Health ◽  
Type 2 Diabetes ◽  
Public Health Problem ◽  
Healthcare Systems ◽  
Major Public Health Problem ◽  
Human History ◽  
The Past ◽  
The Usa ◽  
Diabetes And Obesity

The prevalence of diabetes is increasing worldwide and nowadays stands as a major public health problem. Undoubtedly, the 21st century has the most diabetogenic environment in human history. The number of people living with diabetes has soared to 366 million, and the disease kills one person every seven seconds, posing a "massive challenge" to healthcare systems worldwide. Diabetes is a huge and growing problem, and the costs to society are high and escalating, affecting all countries. Over the past 25 years or so, the prevalence of type 2 diabetes in the USA has almost doubled, with three- to five-fold increases in India, Indonesia, China, Korea and Thailand. JMS 2011;14(2):38-39.

scholarly journals A comparison of pathogenesis of Diabetes in China and the United States

2021 ◽  
Vol 233 ◽  
pp. 02018
Author(s):  
Hui Wen
Keyword(s):  
Public Health ◽  
United States ◽  
Type 2 Diabetes ◽  
United States Of America ◽  
Public Health Problem ◽  
The United States ◽  
The Difference ◽  
Different Cultures

Diabetes Mellitus is a growing public health problem recent year. Diabetes has two main kinds: type 1 and type 2. Accumulating evidence suggests that genetic predisposition plays an important role in type 1 diabetes. This may be one reason that cause the difference between China and U.S. Within diabetes patients, more than 90% have type 2 diabetes. However, the prevalence of type 2 diabetes in China and United States of America is quite different, with 11.6% and 13% in two countries, respectively. Two countries with completely different cultures and histories have such slight differences in the prevalence of type 2 diabetes. Based on this fact, this paper will introduce the pathogenesis of diabetes and how it differs between the two countries.

scholarly journals Risk Factors for and Barriers to Control Type-2 Diabetes among Saudi Population

2015 ◽  
Vol 8 (9) ◽  
pp. 10 ◽  
Author(s):  
Yahya Mari Alneami ◽  
Christopher L. Coleman
Keyword(s):  
Public Health ◽  
Risk Factors ◽  
Type 2 Diabetes ◽  
Saudi Arabia ◽  
Health Problem ◽  
Literature Search ◽  
Public Health Problem ◽  
Major Public Health Problem ◽  
Saudi Population

<p><strong>BACKGROUND:</strong> The prevalence of Type-2 Diabetes is dramatically increasing in urban areas within Saudi Arabia. Hence, Type-2 Diabetes has now become the most common public health problem. Understanding the major risk factors for and barriers to control Type-2 Diabetes may lead to strategies to prevent, control, and reduce in the burden of disease cases.</p><p><strong>OBJECTIVE:</strong> To describe risk factors for and barriers to control Type- 2 Diabetes in Saudi Arabia.</p><p><strong>METHODS:</strong> The literature search was conducted on risk factors for and barriers to control Type- 2 Diabetes in Saudi Arabia using the databases PubMed, MEDLINE, and Google Scholar (2007-2015). The literature search yielded 80 articles, of which 70 articles were included in this review after excluding non-relevant articles. </p><p><strong>RESULTS:</strong> The literature review revealed that obesity, physical inactivity, unhealthy diet, smoking, and aging are the major risk factors for Type-2 Diabetes in Saudi Arabia. Further, the review allocated a complex set of barriers including, lack of education, social support, and healthy environment. These barriers may hinder Saudis with Type-2 Diabetes from controlling their disease.</p><p><strong>CONCLUSION:</strong> The prevalence of Type-2 Diabetes is high among the Saudi population and represents a major public health problem. Effective research programs are needed to address the modifiable risk factors for and barriers to control Type-2 Diabetes among Saudi population.</p>

scholarly journals Digital Support for Healthier Eating Habits Among Patients With Type 2 Diabetes: Protocol for a Randomized Clinical Trial Within Primary Care (HAPPY Trial)

10.2196/24422 ◽  
2020 ◽  
Vol 9 (11) ◽  
pp. e24422
Author(s):  
Ylva Trolle Lagerros ◽  
Anna Dahlgren ◽  
Linnea Sjöblom ◽  
Stephanie E Bonn
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Dietary Intake ◽  
Randomized Clinical Trial ◽  
Healthy Eating ◽  
Eating Habits ◽  
Lifestyle Factors ◽  
Smartphone App ◽  
Healthy Eating Habits

Background Despite the large impact that dietary habits have in the management of diabetes, few tools for supporting healthy eating habits are available for persons with diabetes. Objective The aim of this randomized clinical trial is to evaluate the effect of a 12-week, mobile health (mHealth), app-based intervention promoting healthy eating habits among patients with type 2 diabetes. Methods The HAPPY (Healthy eating using APP technologY) trial is a randomized clinical trial with two arms aiming to include 200 patients, 18 years of age or older, with type 2 diabetes. Both women and men are eligible for inclusion. Study participants are randomized 1:1 to an intervention group, where they are instructed to use a smartphone app promoting healthy eating, or to a control group, where they receive standard primary care only, for a period of 12 weeks. Each week a new topic (eg, vegetable intake) is introduced via the app. After an introduction text, the user is given a topic-related activity to perform (eg, eat one additional serving of vegetables per day during that week). The app records daily progress and sends automatic reminders or feedback to the user. Dietary intake, body composition, clinical variables, and biomarkers are measured at baseline and at 3- and 6-month follow-ups. An extensive web-based questionnaire comprising several validated questionnaires assessing a number of lifestyle factors is distributed via email at baseline and at 3-, 6-, and 12-month follow-ups; lifestyle factors include, for example, sleep, physical activity, eating behavior, and health-related quality of life. The effect of the intervention on dietary intake (primary outcome) and on glycated hemoglobin and blood lipid levels, body composition, blood pressure, other lifestyle factors, and overall health (secondary outcomes) will be assessed. Results Data collection is ongoing. Recruitment of participants started in January 2019. Findings from the study are expected to be published by the end of 2021. Conclusions Technology development provides new ways to promote and support long-term adherence to healthier eating habits. mHealth-based approaches allow for real-time interaction and the delivery of an intervention at any time. Further, focusing on overall diet allows the user to apply new knowledge to current eating patterns, creating an individualized approach. In this study, we evaluate the effect of using a new smartphone app promoting healthy eating habits on dietary intake, clinical markers, and lifestyle factors among patients with type 2 diabetes. Trial Registration ClinicalTrials.gov NCT03784612; https://clinicaltrials.gov/ct2/show/NCT03784612 International Registered Report Identifier (IRRID) DERR1-10.2196/24422

scholarly journals The Role of Lifestyle, Eating Habits and Social Environment in the Prevention and Treatment of Type 2 Diabetes and Hypertension

Nutrients ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 1460
Author(s):  
Kalliopi Karatzi ◽  
Yannis Manios
Keyword(s):  
Type 2 Diabetes ◽  
Social Environment ◽  
Eating Habits ◽  
Health Problems ◽  
Major Health ◽  
The Past ◽  
Prevention And Treatment

Type 2 diabetes (T2DM) and hypertension are major health problems, with an undisputed growth burden in the past decades [...]

scholarly journals Approach to the Patient with Diabetes during Pregnancy

2010 ◽  
Vol 95 (8) ◽  
pp. 3578-3585 ◽  
Author(s):  
Jennifer Hone ◽  
Lois Jovanovič
Keyword(s):  
Public Health ◽  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Weight Gain ◽  
Preconception Care ◽  
Fetal Outcomes ◽  
Optimal Outcomes

The epidemics of obesity and type 2 diabetes mellitus (T2DM) globally are paralleling an increase in the number of women with T2DM becoming pregnant. Because T2DM is frequently undiagnosed before pregnancy, the risk of major malformations in the developing fetus is increased due to uncontrolled hyperglycemia. The lack of preconception care and the increase in complications of pregnancy due to the coexistence of obesity and T2DM are of concern from both an individual and a public health standpoint. Rapid achievement of normoglycemia with limited weight gain is critical to optimize maternal and fetal outcomes in all women with diabetes during pregnancy, regardless of the type of diabetes. This article will focus on T2DM preceding pregnancy due to its increasing prevalence and potentially dire fetal and maternal consequences. Euglycemia before, during, and after all pregnancies complicated by diabetes results in the best opportunity for optimal outcomes for mother and infant.

Sign in / Sign up

Export Citation Format

Share Document